Limited published data about periprocedural myocardial injury (PMI) after successful chronic total occlusion (CTO)-percutaneous coronary intervention (PCI) were available. The study aimed to investigate risk predictors and clinical implications of PMI after successful CTO-PCI and drug-eluting stent (DES) implantation. Between 2009and 2012, a total of 437 patients who underwent successful recanalization with DESs were included. All the cardiac troponin T (cTnT)-positive patients were excluded. As the benchmark in PMI defined as cTnT .5 × the 99th percentile ULN, the independent predictors and major adverse cardiac events (MACEs) involving cardiac death, myocardial infarction, and target-vessel revascularization were compared between the PMI group and the no PMI group. The incidence rate of PMI was 18.3% (80/437) after the index procedure. Multivariate analysis showed that calcification (OR: 2.203, confidence interval [CI] 1.262-3.845, P ¼ 0.005), the parallel wire technique (OR: 3.178, CI 1.661-6.081, P , 0.001), and the retrograde wire technique (OR: 5.554, CI 2.275-13.558, P , 0.001) were independent predictors of PMI after successful CTO-PCI and DES implantation. Major adverse cardiac events were significantly higher in the PMI group (adjusted hazard ratio 3.704; 95% CI 1.759-7.796; P ¼ 0.001) during the 3-year follow-up. The independent predictors of PMI after successful recanalization with DESs are calcification, the parallel wire technique, and the retrograde wire technique. Periprocedural myocardial injury after the index procedure is associated with more adverse clinical events. Further large clinical studies combined with bioinformatics are warranted to explore the implications of patients with this distinct new entity.
Introduction
Periprocedural myocardial injury (PMI) is relatively common after percutaneous coronary interventions (PCIs) been proved to predispose worse prognosis, [6] [7] [8] which was defined as a troponin elevation of .5 the upper limit of normal (ULN), an update of cut-off point, referring to the third universal definition of PMI (type 4a). 9 However, the prognostic value of PMI assessed by different biomarkers and threshold is still a matter of debate. 10, 11 In spite of the remarkable progress in the technologies and techniques achieved in the PCI for chronic total occlusions (CTOs) over the last decade and the rate of procedural success being up to 80-90% in some centres across the world, recanalization for CTOs of native coronary arteries remains challenging, and is still regarded as the 'last frontier' of PCI. 12 In addition, various iatrogenic injuries during PCI such as dissection, 13 side-branch occlusion 14 , and distal embolization 15 were reported to be associated with PMI, thereby yielding better clinical outcomes with decreased complications through the successful recanalization of CTOs could be expected.
Up to now, with various case reports focusing on CTO-PCI and drug-eluting stent (DES) implantation published in journals, safety concerns have been gradually raised. However, only one retrospective study is available regarding the clinical outcome of PMI after successful CTO-PCI, 16 which needs to be prudently evaluated through analysis of additional study with a larger population. Therefore, we designed the current study to investigate the incidence, independent predictors, and clinical outcomes of PMI for patients undergoing successful CTO interventions with DES implantation.
Methods

Study population
From May 2009 to December 2012, a total of 437 cardiac troponin T (cTnT)-negative patients with successful recanalization of CTOs in the native coronary arteries at the Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital of Fudan University and Chronic Total Occlusion Club, China (CTOCC), were consecutively included in the study. The procedural success rate of CTO-PCI was 81.4% for the same period. Patients enrolled in the current study were divided into the PMI group and the no PMI group according to the presence of PMI after successful CTO-PCI with DES implantation.
All the percutaneous revascularizations of CTOs were performed according to the current standard guidelines. All patients without contraindication received a loading dose of 300 mg aspirin (97.3%) and clopidogrel (100%). After operation, patients were advised to maintain their lifelong aspirin therapy, and at least a 12-month clopidogrel prescription. Blood samples were drawn from all patients before PCI and at 24 h after intervention for measurement of cTnT concentrations.
Each CTO-PCI was performed by at least two different operators from our centre or CTOCC. All of the operators achieved .300 PCIs per year. The study protocol was approved by the hospital's medical ethics committee. All patients provided written informed consent before participating in the procedure.
Definitions
Chronic total occlusion is defined as thrombolysis in myocardial infarction (TIMI) grade 0 flow and the duration of coronary occlusion is ≥3 months. 12 In the absence of serial angiograms, the duration of coronary occlusion is instead estimated from available clinical information related to the event that caused the occlusion (e.g. acute MI or sudden change in angina pattern with ECG changes consistent with the location of the occlusion). 12 Angiographic success was defined as a restoration of TIMI flow grade 3 in the target vessel after DES implantation and a residual stenosis of ,10% by visual estimation.
Periprocedural myocardial injury is defined by the elevation of cTnT values (.5 × 99th percentile ULN). 9 The angiographic indices examined were the locations of the CTO, PMI, diffuse disease proximal to the occlusion (at least one stenosis of .50% proximal to the occlusion), 17 side branch at the occlusion, vessel tortuosity (the presence of at least one bend of .458 proximal to the occlusion), 17 calcification at the site of the occlusion (radioopacity present before contrast injection), ostial occlusion (occlusion within 3 mm of the ostial), stump morphology (a blunt or tail-like stump), and grades of bridging collaterals (0 ¼ none; 1 ¼ filling of side branches of the artery to be dilated via collateral channels without visualization of the epicardial segment; 2 ¼ partial filling of the epicardial segment via collateral channels; 3 ¼ complete filling of the epicardial segment of the artery being dilated via collateral channels). 18 Angiographic restenosis was defined as a ≥50% diameter stenosis within the target lesion.
All of the films were reviewed by at least two qualified interventional doctors. If there was any ambiguity in the reports or films, the films were reviewed independently by the third well-qualified interventional doctor.
Study endpoints
The clinical follow-up duration of patients in both groups was defined as the time from the first successful CTO-PCI to 31 December 2013. The major adverse cardiac events (MACEs), including cardiac death, myocardial infarction (MI), target-vessel revascularization (TVR), were recorded. Myocardial infarction was defined as the elevation of the cardiac troponin with at least one value above the 99th percentile of the ULN and with at least one of the following: (i) symptoms of ischaemia, (ii) new or presumably new significant ST-segment-T wave (ST-T) changes or new left bundle branch block, (iii) development of pathological Q waves in the ECG, (iv) imaging evidence of new loss of viable myocardium, or new regional wall motion abnormality, and (v) identification of an intracoronary thrombus by angiography or autopsy. 9 Targetvessel revascularization was defined as emergency or elective coronary artery bypass graft or repeat PCI in the target vessel.
Statistical analysis
The data were expressed as the mean + SD for the continuous variables, and as frequencies for the categorical variables. The comparison of continuous variables was performed by the independent Student's t-test or the Mann-Whitney U-test as appropriate. Statistical analysis of the categorical variables was performed using the Pearson x 2 or Fisher's exact test as appropriate. The multivariate logistic regression model (all variables found to have univariate association with PMI after CTO-PCI and P , 0.1 were included into the analysis) was used to identify the independent predictors of PMI after successful CTO-PCI and DES implantation. Cumulative incidence was estimated by the Kaplan-Meier method, and differences were assessed with the log-rank test. We used Cox proportional hazard models to estimate the risk of the PMI for clinical outcomes adjusting for the differences in patient baseline, angiographic, and procedural factors. P-values were two-tailed, and a value of P , 0.05 was considered statistically significant. The data were analysed with the SPSS v.20.0 statistical software (SPSS, version 20.0, Inc., Chicago, IL, USA).
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Results
Between May 2009 and December 2012, a total of 437 patients with successful recanalization of CTOs were analysed in the study. Periprocedural myocardial injury was observed in 18.3% (80/437) of the enrolled population. Aspirin was applied after discharge for 97.5% (78/80) of patients with PMIs and 97.2% (347/357) of patients without PMIs. Clopidogrel (at least a 12-month administration) was definitely applied after discharge to all the patients included in the current study. The main reason for discontinuing aspirin was gastrointestinal side-effect or bleeding.
Baseline clinical characteristics
The baseline clinical characteristics of the patients are presented in Table 1 . The mean age of our cohort was 62.19 + 11.12 years. As is common in CTO-PCI series, male was the dominant group in the overall patients. The prevalence of current smokers was 27.5%, and history of hypertension and MI was 65.2 and 29.7%, respectively. A significant difference in the age (64.76 + 11.03 vs. 61.61 + 11.08 years, P ¼ 0.022) was shown between the PMI group and the no PMI group, whereas there were no significant differences among the other baseline clinical characteristics between the two groups. Left anterior descending artery was the most common site of CTO in this study (202/437, 46.2%). Most of CTO's morphological characteristics, which were acknowledged to be associated with procedural success, showed no significant difference between the two groups. In particular, calcification (45.0 vs. 25.8%, P ¼ 0.001) was the only risk factor associated with PMI after successful CTO-PCI with DESs.
Angiographic and procedural characteristics
Procedural characteristics
The procedural characteristics including devices and techniques are given in Table 3 
Multiple logistic regression analysis
The multiple logistic regression analysis ( Mid-term follow-up of PMI after CTO-PCI B59
were the independent predictors of the occurrence of PMI after successful CTO-PCI with DES implantation.
Outcomes
During the mid-term follow-up (median duration: 763 days; interquartile range: 446-1135 days), 404 patients (92.4%) completed follow-up. Kaplan-Meier estimates of the MACEs in the two study groups are shown in Figure 1 . During 3-year follow-up, 17.5% of patients in the PMI group and 6.4% of patients in the no PMI group experienced MACEs ( Figure 1A ). The event rates for cardiac death were 1.3 and 0.3% in the two groups of patients. Myocardial infarction was observed in 5 (6.3%) patients in the PMI group and 5 (1.4%) in the no PMI group ( Figure 1B) . Target-vessel revascularization occurred in 10 (12.5%) patients in the PMI group and Figure 1C) . Overall, there were significantly statistical differences of MACEs between the two groups under the dual antiplatelet therapy (adjusted hazard ratio 3.704; 95% CI 1.759-7.796; P ¼ 0.001; Table 5 ).
Discussion
The PMI study that enrolled a large cohort of patients (over 400) undergoing successful CTO intervention from 2009 to 2012, for the first time, adopted the new index-cTnT .5 × the 99th percentile ULN-to indicate that the independent predictors of the occurrence of PMI after the successful CTO-PCI and DES implantation included calcification, the parallel wire technique, and the retrograde wire technique in multivariate analysis. Furthermore, successful CTO-PCI with DESs also demonstrated that the PMI group after the index procedure, compared with the no PMI group, was associated with higher occurrence of MACEs, even under dual antiplatelet therapy during 3-year follow-up. These results could improve our understanding of therapeutic intervention in cardiovascular diseases, especially in the era of DES implantation. Mid-term follow-up of PMI after CTO-PCI B61
The incidence of periprocedural myocardial injury following successful chronic total occlusion-percutaneous coronary intervention with drug-eluting stentss
Periprocedural myocardial injury was not rare, and one of the prognostically important complications of routine PCI in cardiovascular diseases. Although published data about the incidence of PMI could be available online, it remains a controversial issue for the sake of different biomarkers and thresholds. 11 According to the data of a meta-analysis from 65 studies listing complications after CTO-PCI, the incidence of periprocedural MI was 2.5% (95% CI: 1.9-3.0%). 19 Contrary to these many articles to referred to, it was reported that there was only one retrospective study focusing on the impact of PMI on clinical outcomes after successful CTO-PCI. 16 Using the definition of creatine kinase-myocardial band (CK-MB) .3, the ULN, this retrospective study 16 that adopted the retrograde approach in 26.8% of all procedures revealed that the incidence of PMI was 8.6% (95% CI: 5.8-12.2%) after successful CTO-PCI. In addition, the frequency of periprocedural cardiac troponin elevation .3×, .10×, and .20 × ULN was 61, 43, and 31%, respectively. Under these conditions that a large amount of information about the prognostic value of the new cut-off point defined by the third universal definition of MI was not provided by researchers in different heart research centres around the world, our PMI study took the lead in investigating the clinical outcomes of PMI following the successful revascularization of CTOs, and indicated that the incidence of PMI after successful CTO-PCI with DESs was 18.3%. The finding showed the relatively more accurate estimate of the occurrence of PMI, compared with the prior study using old inclusion criteria. The difference in the incidence of PMI might be mainly attributed to the discrepancy between evaluation method and PMI definition. The reason for causing this situation lies in the fact that, compared with data using CK-MB, use of cardiac troponin would have led to a five-fold or more increase in the diagnosis of PMI. 20 Another part for the explanation of this case was the different characteristics of the population enrolled in the current study, such as age and calcification. Majority of the patients with unstable angina (UA) in our study had 'increasing angina' even in some 'certain CTO (angiographically confirmed)' cases. Although incidence of UA in this study was higher than many previous studies. The study by Prasad et al. 21 reported as high as 51-72% incidence of UA in CTOs. So, we thought patients with UA should not be excluded and on the contrary its impact on PMI and clinical outcomes should be analysed. The result of our study showed no increase of PMI after CTO-PCI in this special group.
Procedural factors of periprocedural myocardial injury following successful chronic total occlusion-percutaneous coronary intervention with drug-eluting stents Due to the advancement of PCI technologies and the improvement of PCI techniques in cardiology during the most recent time period, great progress has been made in procedural success rates of revascularization of CTOs. Howbeit, this benefit was always gained with a discount, as a result of a number of risk factors associated with clinical complications, like PMI. Iatrogenic injuries to the vessel and/or myocardium were associated with poor clinical outcomes, similar to the risk factors of baseline and lesion characteristics, among which, age 22, 23 and calcification 11 have been fully reported in published articles. It is known to us that the parallel wire technique and the retrograde wire technique overcome technical bottlenecks for revascularization of CTOs to some extent and, thus, improve success the rate of CTO-PCI. In this study, the single-wire technique was the predominant strategy followed by the parallel wire technique. Generally, when the single-wire technique was applied to fail to run through the real lumen, then the parallel wire technique logically became the primary basic technique for CTO-PCI. Nevertheless, in spite of its contribution to the success of CTO-PCI, the parallel wire technique seemed to be associated with significant occurrence of PMI formation. The potential cause was that the first wire had already entered the subintima, and created a false lumen before the parallel wire technique was performed. Even though the second wire increased the success rate of CTO-PCI, the parallel wire technique could not remedy, and improve the pre-existing damage to the artery wall. In recent years, the retrograde wire technique was commonly performed in daily CTO-PCI. Our finding about this technique shared the same conclusion with a previously reported study. 16 Clinical outcomes of periprocedural myocardial injury following successful chronic total occlusion-percutaneous coronary intervention with drug-eluting stents Successful CTO revascularization could potentially bring a range of clinical benefits to patients, including the improvement of left ventricular function, the prevention of further ventricular remodelling, and the decrease of the risk of MACEs. However, real clinical benefits to this population need to be reasonably evaluated in consideration of the occurrence of complications. Previous studies of patients undergoing non-emergency PCI, utilizing either CK-MB myocardial band or troponin to definite PMI, had shown that PMI was an adverse long-term prognosticator. [6] [7] [8] 22, 24 At present, as a new threshold for the definition of PMI, the clinical outcomes of cTnT .5 × the 99th percentile ULN to define PMI in PCI-CTO have not been definitively determined. Hereby, it is very important and necessary for assessing and detecting potentially harmful complications of PMI after successful CTO-PCI with DESs. To determine if UA and other clinical factors have potential impact on our result about MACE, we took these factors into our Cox proportional hazard models to adjust the risk of the PMI for clinical outcomes. In the current study, PMI after successful revascularization of CTOs was significantly associated with MACEs with the occurrence of 17.5%, emphasizing the fact that there is potential for harm to the collateral circulation, branch vessel occlusion, or distal embolization when treating chronic total occluded vessels. Although no statistical difference of cardiac death between two groups was found, PMI increased the risk of the occurrence of MI and/or TVR, reflecting that PMI was not benign, and was associated with adverse clinical events even under the current dual antiplatelet regimen, which also might result from the iatrogenic vessel injury involving residual dissection or subintima stent implantation.
In conclusion, this PMI study demonstrated that as the new benchmark in PMI defined as cTnT .5 × the 99th percentile ULN, the risk factors of PMI after successful CTO-PCI with DESs were calcification, the parallel wire technique, and the retrograde wire technique. The PMI group after the index procedure, compared with the no PMI group, was associated with more adverse clinical events under dual antiplatelet therapy. For making a more convincing conclusion, further prospective, randomized, and large clinical studies will be needed to investigate the clinical implications.
Limitation
The current study had one limitation that the precise duration of the occlusion was not angiographically documented, a limitation applicable to all observational studies of CTOs.
